LeonMB.SmithCR.MackMet al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med2010; 363: 1597–1607.20961243
2.
MackMJ.LeonMB.ThouraniVHet al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med2019; 380: 1695–1705.30883058
3.
Muller MoranHR.EikelboomR.LodewyksCet al. Two-year outcomes from the PARTNER 3 trial: where do we stand?Curr Opin Cardiol. Epub ahead of print 16 October 2020.doi:10.1097/HCO.000000000000081333060389
4.
PopmaJJ.DeebGM.YakubovSJet al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med2019; 380: 1706–1715.30883053
5.
CarrollJD.MackMJ.VemulapalliSet al. STS-ACC TVT Registry of transcatheter aortic valve replacement. J Am Coll Cardiol2020; 76: 2492–2516.33213729
6.
ThouraniVH.EdelmanJJ.HolmesSDet al. The International Society for Minimally Invasive Cardiothoracic Surgery expert consensus statement on transcatheter and surgical aortic valve replacement in low- and intermediate-risk patients: a meta-analysis of randomized and propensity-matched studies. Innovations2021; 16: 3–16.33491539
7.
ZhangD.MaoX.LiuDet al. Transcatheter versus surgical aortic valve replacement in low to intermediate surgical risk aortic stenosis patients: a systematic review and meta-analysis of randomized controlled trials. Clin Cardiol2020; 43: 1414–1422.32926456
8.
KhanSU.LoneAN.SaleemMAet al. Transcatheter versus surgical aortic-valve replacement in low- to intermediate-surgical-risk candidates: a meta-analysis and systematic review. Clin Cardiol2017; 40: 974–981.29168984
9.
AndoT.AshrafS.VillablancaPet al. Meta-analysis of effectiveness and safety of transcatheter aortic valve implantation versus surgical aortic valve replacement in low-to-intermediate surgical risk cohort. Am J Cardiol2019; 124: 580–585.31200922
10.
MakkarRR.ThouraniVH.MackMJet al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med2020; 382: 799–809.31995682
11.
HalimSA.EdwardsFH.DaiDet al. Outcomes of transcatheter aortic valve replacement in patients with bicuspid aortic valve disease: a report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circulation2020; 141: 1071–1079.32098500
12.
FanJ.FangX.LiuCet al. Brain injury after transcatheter replacement of bicuspid versus tricuspid aortic valves. J Am Coll Cardiol2020; 76: 2579–2590.33243378
13.
MakkarRR.YoonS-H.LeonMBet al. Association between transcatheter aortic valve replacement for bicuspid versus tricuspid aortic stenosis and mortality or stroke. JAMA2019; 321: 2193–2202.31184741
14.
De BackerO.LandesU.FuchsAet al. Coronary access after TAVR-in-TAVR as evaluated by multidetector computed tomography. JACC Cardiovasc Interv2020; 13: 2528–2538.33153567
15.
TamDY.WijeysunderaHC.NaimarkDet al. Impact of transcatheter aortic valve durability on life expectancy in low-risk patients with severe aortic stenosis. Circulation2020; 142: 354–364.32493077
16.
AuffretV.PuriR.UrenaMet al. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation2017; 136: 1049–1069.28893961
17.
ThyregodHGH.SteinbrüchelDA.IhlemannNet al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol2015; 65: 2184–2194.25787196
18.
AljabbaryT.QiuF.MasihSet al. Association of clinical and economic outcomes with permanent pacemaker implantation after transcatheter aortic valve replacement. JAMA Netw Open2018; 1: e180088.30646053
19.
BraghiroliJ.KapoorK.ThielhelmTPet al. Transcatheter aortic valve replacement in low risk patients: a review of PARTNER 3 and Evolut low risk trials. Cardiovasc Diagn Ther2020; 10: 59–71.32175228
20.
ThyregodHGH.IhlemannN.JørgensenTHet al. Five-year clinical and echocardiographic outcomes from the Nordic Aortic Valve Intervention (NOTION) randomized clinical trial in lower surgical risk patients. Circulation. Epub ahead of print 01 February 2019.doi:10.1161/CIRCULATIONAHA.118.03660630704298
21.
SeiffertM.WaltherT.HammCet al. The DEDICATE Trial: an independent all-comers trial of transcatheter aortic valve implantation vs. surgical aortic valve replacement in patients at low to intermediate operative risk is recruiting patients. Eur Heart J2019; 40: 331–333.30668699
